| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5953661 | Chest | 2015 | 9 Pages |
Abstract
VPI together with tumor size has a synergistic effect on survival in node-negative NSCLC. Patients with stage IB NSCLC and larger tumor size with VPI might be considered for adjuvant chemotherapy after surgical resection and need careful preoperative evaluation and postoperative follow-up. Further randomized clinical trials to determine the impact of adjuvant chemotherapy in patients with stage IB NSCLC with VPI are warranted.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Long MD, Wenhua MD, PhD, Jianfei MD, PhD, Xiaofang PhD, Xiaoshun MD, Jiaxi MD, PhD, Chenglin MD, PhD, Jianxing MD, PhD,